Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Usha Lee McFarling is a former STAT reporter. Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned the consideration of race in ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Sullivan is professor of health economics and policy and former dean of pharmacy at the University of Washington. Hansen is professor of health economics and policy and chair of the Department of ...

The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable showdown with ...

Jeffery Taubenberger, the acting head of the NIAID, the NIH’s infectious disease institute, is reported to have stepped down.

Far fewer knew that mpox and Zika can also be transmitted sexually. And most respondents understood the main ways that these ...

A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...

Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a randomized ...

Supporters worry that a men’s health office created by the Trump administration risks being dismantled by a future Democratic ...

Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The ...